Platforms, Therapeutic Areas and Product Portfolio CSL research and development leverages its expertise in four strategic platforms – plasma protein technology; recombinant protein technology; cell and genetic medicines; and vaccines technology. PLATFORMS Plasma Protein Technology Recombinant Protein Technology Genetic Medicine Vaccines Technology THERAPEUTIC AREAS These platforms underpin CSL’s five therapeutic areas: 20 Performance
RkJQdWJsaXNoZXIy MjE2NDg3